SCHEMBL4919783

SCHEMBL4919783

Cc1cc(=O)oc2cc(-c3ccc4c(ccn4C(=O)OC(C)(C)C)c3)ccc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA12 O43570 4/20 0.50
▸ CA9 Q16790 4/20 0.50
▸ CA1 P00915 3/20 0.50
▸ KDR P35968 3/20 0.43
▸ PIK3CD O00329 2/20 0.43
▸ ABL1 P00519 2/20 0.43
▸ EGFR P00533 2/20 0.43
▸ HCK P08631 2/20 0.43
▸ SRC P12931 2/20 0.43
▸ PIK3CA P42336 2/20 0.43
▸ PIK3CB P42338 2/20 0.43
▸ MTOR P42345 2/20 0.43
▸ PIK3CG P48736 2/20 0.43
▸ EPHB4 P54760 2/20 0.43
▸ PRKDC P78527 2/20 0.43
▸ PI4KB Q9UBF8 2/20 0.43
▸ AR P10275 1/20 0.43
▸ ALDH1A1 P00352 11/20 0.42
▸ KDM4E B2RXH2 10/20 0.42
▸ GAA P10253 7/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13247916 0.78 PIK3CD (0.51) KDRPIK3CDABL1EGFRHCK
SCHEMBL3902843 0.76 PIK3CD (0.51) KDRPIK3CDABL1EGFRHCK
SCHEMBL2458509 0.76 ACLY (0.52) KDRPIK3CDABL1EGFRHCK
SCHEMBL22130186 0.75 PIK3CD (0.55) KDRPIK3CDABL1EGFRHCK
SCHEMBL4929175 0.75 EP300 (0.56) KDRPIK3CDABL1EGFRHCK
SCHEMBL3964381 0.74 PIK3CD (0.52) KDRPIK3CDABL1EGFRHCK
SCHEMBL31253112 0.74 PIK3CD (0.49) KDRPIK3CDABL1EGFRHCK
SCHEMBL4929921 0.73 CA12 (0.48) CA12CA9CA1KDRAR
SCHEMBL14088014 0.73 CA12 (0.48) CA12CA9CA1KDRAR
SCHEMBL3269495 0.73 PIK3CD (0.47) KDRPIK3CDABL1EGFRHCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080194522-A1 Development of Fluorogenic Substrates For Monoamine Oxidases (Mao-A and Mao-B) TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK, THE 2008-08-14 — — US disclosed
US-20080194522-A1 Development of Fluorogenic Substrates For Monoamine Oxidases (Mao-A and Mao-B) TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK, THE 2008-08-14 — — US disclosed
US-20080194522-A1 Development of Fluorogenic Substrates For Monoamine Oxidases (Mao-A and Mao-B) TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK, THE 2008-08-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080194522-A1 Development of Fluorogenic Substrates For Monoamine Oxidases (Mao-A and Mao-B) MAOA, MAOB, COMT CA12 3628/4885CA9 2007/4885CA1 1732/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback